CenterBook Partners’s Transmedics TMDX Stock Holding History

CenterBook Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,552	Closed	-$310K	–	779
2025 Q4	$310K	Buy	+2,552	New	+$320K	0.02%	522
2025 Q1	–	Sell	-8,369	Closed	-$522K	–	599
2024 Q4	$522K	Buy	+8,369	New	+$779K	0.03%	411

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CenterBook Partners's TMDX Position: Q1 2026 in Review

CenterBook Partners sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 2,552 shares — an estimated $310K sold.

CenterBook Partners first reported a position in TMDX in Q4 2024 and held it in 2 quarters. The position peaked at $522K in Q4 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

CenterBook Partners reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
CenterBook Partners sold 2,552 Transmedics shares in Q1 2026, an estimated $310K.
CenterBook Partners first reported a position in Transmedics in Q4 2024 and held it in 2 quarters.
CenterBook Partners's Transmedics position peaked at $522K in Q4 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.